| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 14, 2014New feeding tube with integrated camera designed to deliver enhanced patient safety
DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 14, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo™ feeding tube with IRIS Technology....
-
Apr 11, 2014
MINNEAPOLIS - April 11, 2014 - The Federal District Court of Delaware today granted in part Edwards Lifesciences' motion for a preliminary injunction that prevents Medtronic, Inc. (NYSE: MDT) from...
-
Apr 11, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 11, 2014-- Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™...
-
Apr 10, 2014Landmark BLOCK HF Trial Demonstrates Clinical Benefits of Biventricular Pacing in New Patient Population
MINNEAPOLIS - April 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with...
-
Apr 10, 2014
MINNEAPOLIS - April 10, 2016 - This weekend, an article was published in the Minneapolis Star Tribune that criticized Medtronic's handling of data collected during a retrospective chart review...
-
Apr 9, 2014Evera MRI(TM) ICD System Is First to Combine Proven Treatment Performance, Increased Longevity, Improved Comfort with Full-Body MRI Access
MINNEAPOLIS - April 9, 2014 - Medtronic today announced CE (Conformité Européenne) Mark and European launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System,...
-
Apr 7, 2014
ISTANBUL - April 7, 2014 - Medtronic, Inc. today announced that one of its subsidiaries has acquired a majority of the shares of Biostar, which will assume the distribution of Medtronic products...
-
Apr 5, 2014Interventional Treatment of Lower-Extremity Peripheral Arterial Disease With Novel Medical Device Shows Positive Results in IN.PACT SFA Trial
LONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated...
-
Mar 31, 2014Final Follow-up of CoreValve CE Pivotal Study Shows Sustained Valve Function
MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...
-
Mar 30, 2014
MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent...
-
Mar 30, 2014Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry Presented at ACC.14
MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...
-
Mar 30, 2014Has Repaired Hearts of 6,000+ Patients; More Than Half Are Children
MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...
-
Mar 29, 2014Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal TrialCoreValve High Risk Study: FDA Determines Expert Panel Not Required
MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...
-
Mar 29, 2014Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA
MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
-
Mar 28, 2014
DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...
-
Mar 27, 2014Study Will Assess Defibrillator Therapy in Patients Most At-Risk for SCA
Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...
-
Mar 25, 2014
DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...
-
Mar 19, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...
-
Mar 19, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting. Seven proposals were on the meeting agenda: Election of...
-
Mar 14, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 14, 2014-- Covidien plc (NYSE: COV) will report second-quarter fiscal 2014 results on April 25. The company will host a conference call for investors at 8:30...
-
Mar 13, 2014Innovative Mesh Designed to Simplify Surgeon Experience, Offer Patients Optimal Hernia Repairs
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 13, 2014-- Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite...
-
Mar 10, 2014"Global Heroes" Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...
-
Mar 7, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Mar 6, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 6, 2014-- Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13. Charles J. Dockendorff, executive...
-
Mar 3, 2014New acute care ventilator delivers advanced breath technology for enhanced patient comfort and clinician ease of use
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 3, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...